Stephanie Collier, MD, MPH, and Talia Puzantian, PharmD. Dr. Collier and Dr. Puzantian have no financial relationships with companies related to this material.
Consider other treatments before reaching for brexpiprazole, even though it’s FDA-approved to treat agitation in dementia due to Alzheimer’s disease.